Skip to main content
Erschienen in: World Journal of Surgery 5/2010

01.05.2010

Nerve Growth Factor-β Expression Is Associated with Lymph Node Metastasis and Nerve Infiltration in Human Hilar Cholangiocarcinoma

verfasst von: Lei-bo Xu, Chao Liu, Guo-quan Gao, Xian-huan Yu, Rui Zhang, Jie Wang

Erschienen in: World Journal of Surgery | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Angiogenesis and lymphangiogenesis are important processes in the progression of malignant tumors. Previous studies have shown that nerve growth factor-β (NGF-β) can promote the initiation and progression of many tumors. In addition, vascular endothelial growth factor-C (VEGF-C) has become recognized as the most important lymphangiogenic factor. In the present study, the expression of NGF-β in human hilar cholangiocarcinoma and its relationship with lymphangiogenesis, lymph node metastasis, nerve infiltration, and VEGF-C expression was investigated.

Methods

Nerve growth factor-β and VEGF-C expression were investigated by immunohistochemistry in samples from 28 cases of hilar cholangiocarcinoma. The lymphatic vessel density (LVD) in the tumor tissue that indicated lymphangiogenesis were calculated by immunostaining with the lymphendothelial-specific antibody D2-40. The relationship between NGF-β expression and VEGF-C expression, lymphangiogenesis, lymph node metastasis, and nerve infiltration was evaluated.

Results

The overexpression of NGF-β and VEGF-C occurred in 57.1% (16/28) and 46.4% (13/28) of tumor samples, respectively. Nerve growth factor-β overexpression was highly correlated with VEGF-C overexpression (P = 0.005), LVD (P < 0.001), lymph node metastasis (P = 0.021), nerve infiltration (P = 0.019), and tumor stage (P = 0.040). Furthermore, VEGF-C overexpression was highly correlated with LVD (P < 0.001) and lymph node metastasis (P < 0.001). However, there was no statistic significance in the relation between NGF-β expression and sex (P = 0.185), age (P = 0.387), maximal tumor size (P = 0.736), Bismuth classification (P = 0.627) as well as histological grade (P = 0.203).

Conclusions

Nerve growth factor-β might promote lymph node metastasis and nerve infiltration in human hilar cholangiocarcinoma.
Literatur
1.
Zurück zum Zitat Tsao JI, Nimura Y, Kamiya J et al (2000) Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann Surg 232:166–174CrossRefPubMed Tsao JI, Nimura Y, Kamiya J et al (2000) Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann Surg 232:166–174CrossRefPubMed
2.
Zurück zum Zitat Jemal A, Thomas A, Murray T et al (2002) Cancer statistics. CA Cancer J Clin 52:181–182CrossRef Jemal A, Thomas A, Murray T et al (2002) Cancer statistics. CA Cancer J Clin 52:181–182CrossRef
3.
Zurück zum Zitat Cristofanilli M, Charnsangavej C, Hortobagyi G (2002) Angiogenesis modulation in cancer research: novel clinical approaches. Nat Rev Drug Discov 1:415–426CrossRefPubMed Cristofanilli M, Charnsangavej C, Hortobagyi G (2002) Angiogenesis modulation in cancer research: novel clinical approaches. Nat Rev Drug Discov 1:415–426CrossRefPubMed
4.
Zurück zum Zitat Scavelli C, Vacca A, Di Pietro G et al (2004) Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia 18:1054–1058CrossRefPubMed Scavelli C, Vacca A, Di Pietro G et al (2004) Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia 18:1054–1058CrossRefPubMed
5.
Zurück zum Zitat Liang D, Chang J, Chin A et al (2001) The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis, and hematopoiesis in zebrafish development. Mech Dev 108:29–43CrossRefPubMed Liang D, Chang J, Chin A et al (2001) The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis, and hematopoiesis in zebrafish development. Mech Dev 108:29–43CrossRefPubMed
6.
Zurück zum Zitat Hirakawa S, Brown L, Kodama S et al (2007) VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109:1010–1017CrossRefPubMed Hirakawa S, Brown L, Kodama S et al (2007) VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109:1010–1017CrossRefPubMed
7.
Zurück zum Zitat McCarter MD, Clarke JH, Harken AH (2004) Lymphangiogenesis is pivotal to the trials of a successful cancer metastasis. Surgery 135:121–124CrossRefPubMed McCarter MD, Clarke JH, Harken AH (2004) Lymphangiogenesis is pivotal to the trials of a successful cancer metastasis. Surgery 135:121–124CrossRefPubMed
8.
Zurück zum Zitat Nathanson SD (2003) Insights into the mechanisms of lymph node metastasis. Cancer 98:413–423CrossRefPubMed Nathanson SD (2003) Insights into the mechanisms of lymph node metastasis. Cancer 98:413–423CrossRefPubMed
9.
Zurück zum Zitat Stacker SA, Baldwin ME, Achen MG (2002) The role of tumor lymphangiogenesis in metastatic spread. FASEB J 16:922–934CrossRefPubMed Stacker SA, Baldwin ME, Achen MG (2002) The role of tumor lymphangiogenesis in metastatic spread. FASEB J 16:922–934CrossRefPubMed
10.
Zurück zum Zitat Choi WWL, Lewis MM, Lawson D et al (2005) Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol 18:143–152CrossRefPubMed Choi WWL, Lewis MM, Lawson D et al (2005) Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol 18:143–152CrossRefPubMed
11.
Zurück zum Zitat Kahn HJ, Marks A (2002) A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 82:1255–1257PubMed Kahn HJ, Marks A (2002) A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 82:1255–1257PubMed
12.
Zurück zum Zitat Descamps S, Pawlowski V, Revillion F et al (2001) Expression of nerve growth factor receptors and their prognostic value in human breast cancer. Cancer Res 61:4337–4340PubMed Descamps S, Pawlowski V, Revillion F et al (2001) Expression of nerve growth factor receptors and their prognostic value in human breast cancer. Cancer Res 61:4337–4340PubMed
13.
Zurück zum Zitat Sortino MA, Condorelli F, Vancheri C et al (2000) Mitogenic effect of nerve growth factor (NGF) in LNCaP prostate adenocarcinoma cells: role of the high- and low-affinity NGF receptors. Mol Endocrinol 14:124–136CrossRefPubMed Sortino MA, Condorelli F, Vancheri C et al (2000) Mitogenic effect of nerve growth factor (NGF) in LNCaP prostate adenocarcinoma cells: role of the high- and low-affinity NGF receptors. Mol Endocrinol 14:124–136CrossRefPubMed
14.
Zurück zum Zitat Tokusashi Y, Asai K, Tamakawa S et al (2005) Expression of NGF in hepatocellular carcinoma cells with its receptors in non-tumor cell components. Int J Cancer 114:39–45CrossRefPubMed Tokusashi Y, Asai K, Tamakawa S et al (2005) Expression of NGF in hepatocellular carcinoma cells with its receptors in non-tumor cell components. Int J Cancer 114:39–45CrossRefPubMed
15.
Zurück zum Zitat Ma J, Jiang YM, Jiang YH et al (2008) Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer. J Gastroenterol Hepatol 23:1852–1859CrossRefPubMed Ma J, Jiang YM, Jiang YH et al (2008) Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer. J Gastroenterol Hepatol 23:1852–1859CrossRefPubMed
16.
Zurück zum Zitat Lazarovici P, Marcinkiewicz C, Lelkes PI (2006) Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development. Curr Pharma Des 12:2609–2622CrossRef Lazarovici P, Marcinkiewicz C, Lelkes PI (2006) Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development. Curr Pharma Des 12:2609–2622CrossRef
17.
Zurück zum Zitat American Joint Committee on Cancer (2002) AJCC cancer staging manual, 6th edn. Springer, New York, pp 145–149 American Joint Committee on Cancer (2002) AJCC cancer staging manual, 6th edn. Springer, New York, pp 145–149
18.
Zurück zum Zitat Su JL, Shih JY, Yen ML et al (2004) Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel-mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res 64:554–564CrossRefPubMed Su JL, Shih JY, Yen ML et al (2004) Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel-mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res 64:554–564CrossRefPubMed
19.
Zurück zum Zitat Weidner N (1995) Current pathological methods for measuring intratumoral microvessel density within breast-carcinoma and other solid tumors. Breast Cancer Res Treat 36:169–180CrossRefPubMed Weidner N (1995) Current pathological methods for measuring intratumoral microvessel density within breast-carcinoma and other solid tumors. Breast Cancer Res Treat 36:169–180CrossRefPubMed
20.
Zurück zum Zitat Shaib Y, El-Serag H (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115–125CrossRefPubMed Shaib Y, El-Serag H (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115–125CrossRefPubMed
21.
Zurück zum Zitat Patel T (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33:1353–1357CrossRefPubMed Patel T (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33:1353–1357CrossRefPubMed
22.
Zurück zum Zitat Khan S, Taylor-Robinson S, Toledano M et al (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 37:806–813CrossRefPubMed Khan S, Taylor-Robinson S, Toledano M et al (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 37:806–813CrossRefPubMed
23.
Zurück zum Zitat Shimada K, Sano T, Sakamoto Y et al (2005) Safety and effectiveness of left hepatic trisegmentectomy for hilar cholangiocarcinoma. World J Surg 29:723–727CrossRefPubMed Shimada K, Sano T, Sakamoto Y et al (2005) Safety and effectiveness of left hepatic trisegmentectomy for hilar cholangiocarcinoma. World J Surg 29:723–727CrossRefPubMed
24.
Zurück zum Zitat Wigle JT, Harvey N, Detmar M et al (2002) An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 21:1505–1513CrossRefPubMed Wigle JT, Harvey N, Detmar M et al (2002) An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 21:1505–1513CrossRefPubMed
25.
Zurück zum Zitat Jackson D, Prevo R, Clasper S et al (2001) LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 22:317–321CrossRefPubMed Jackson D, Prevo R, Clasper S et al (2001) LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 22:317–321CrossRefPubMed
26.
Zurück zum Zitat Mobius C, Freire J, Becker I et al (2007) VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus. World J Surg 31:1768–1774CrossRefPubMed Mobius C, Freire J, Becker I et al (2007) VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus. World J Surg 31:1768–1774CrossRefPubMed
27.
Zurück zum Zitat Shida A, Fujioka S, Ishibashi Y et al (2005) Prognostic significance of vascular endothelial growth factor D in gastric carcinoma. World J Surg 29:1600–1607CrossRefPubMed Shida A, Fujioka S, Ishibashi Y et al (2005) Prognostic significance of vascular endothelial growth factor D in gastric carcinoma. World J Surg 29:1600–1607CrossRefPubMed
28.
Zurück zum Zitat Gu Y, Qi XL, Guo SY (2008) Lymphangiogenesis induced by VEGF-C and VEGF-D promotes metastasis and a poor outcome in breast carcinoma: a retrospective study of 61 cases. Clin Exp Metastasis 25:717–725CrossRefPubMed Gu Y, Qi XL, Guo SY (2008) Lymphangiogenesis induced by VEGF-C and VEGF-D promotes metastasis and a poor outcome in breast carcinoma: a retrospective study of 61 cases. Clin Exp Metastasis 25:717–725CrossRefPubMed
29.
Zurück zum Zitat Jeltsch M, Kaipainen A, Joukov V et al (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423–1425CrossRefPubMed Jeltsch M, Kaipainen A, Joukov V et al (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423–1425CrossRefPubMed
30.
Zurück zum Zitat Thelen A, Scholz A, Benckert C et al (2008) Tumor-associated lymphangiogenesis correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma. Ann Surg Oncol 15:791–799CrossRefPubMed Thelen A, Scholz A, Benckert C et al (2008) Tumor-associated lymphangiogenesis correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma. Ann Surg Oncol 15:791–799CrossRefPubMed
31.
Zurück zum Zitat Saito Y, Nakagami H, Morishita R et al (2006) Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis. Circulation 114:1177–1184CrossRefPubMed Saito Y, Nakagami H, Morishita R et al (2006) Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis. Circulation 114:1177–1184CrossRefPubMed
32.
Zurück zum Zitat Shin JW, Min M, Larrieu-Lahargue F et al (2006) Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis. Mol Biol Cell 17:576–584CrossRefPubMed Shin JW, Min M, Larrieu-Lahargue F et al (2006) Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis. Mol Biol Cell 17:576–584CrossRefPubMed
33.
Zurück zum Zitat Bernabei R, Landi F, Bonini S et al (1999) Effect of topical application of nerve-growth factor on pressure ulcers. Lancet 354:307CrossRefPubMed Bernabei R, Landi F, Bonini S et al (1999) Effect of topical application of nerve-growth factor on pressure ulcers. Lancet 354:307CrossRefPubMed
34.
Zurück zum Zitat Tuveri M, Generini S, Matucci-Cerinic M et al (2000) NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet 356:1739–1740CrossRefPubMed Tuveri M, Generini S, Matucci-Cerinic M et al (2000) NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet 356:1739–1740CrossRefPubMed
35.
Zurück zum Zitat Cantarella G, Lempereur L, Presta M et al (2002) Nerve growth factor–endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J 16:1307–1309PubMed Cantarella G, Lempereur L, Presta M et al (2002) Nerve growth factor–endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J 16:1307–1309PubMed
36.
Zurück zum Zitat Raychaudhuri SK, Raychaudhuri SP, Weltman H et al (2001) Effect of nerve growth factor on endothelial cell biology: proliferation and adherence molecule expression on human dermal microvascular endothelial cells. Arch Dermatol Res 293:291–295CrossRefPubMed Raychaudhuri SK, Raychaudhuri SP, Weltman H et al (2001) Effect of nerve growth factor on endothelial cell biology: proliferation and adherence molecule expression on human dermal microvascular endothelial cells. Arch Dermatol Res 293:291–295CrossRefPubMed
37.
Zurück zum Zitat Graiani G, Emanueli C, Desortes E et al (2004) Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of type 1 diabetic mice. Diabetologia 47:1047–1054CrossRefPubMed Graiani G, Emanueli C, Desortes E et al (2004) Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of type 1 diabetic mice. Diabetologia 47:1047–1054CrossRefPubMed
38.
Zurück zum Zitat Park HJ, Kim MN, Kim JG et al (2007) Up-regulation of VEGF expression by NGF that enhances reparative angiogenesis during thymic regeneration in adult rat. Biochim Biophys Acta Mol Cell Res 1773:1462–1472CrossRef Park HJ, Kim MN, Kim JG et al (2007) Up-regulation of VEGF expression by NGF that enhances reparative angiogenesis during thymic regeneration in adult rat. Biochim Biophys Acta Mol Cell Res 1773:1462–1472CrossRef
39.
Zurück zum Zitat Tammela T, Enholm B, Alitalo K et al (2005) The biology of vascular endothelial growth factors. Cardiovasc Res 65:550–563CrossRefPubMed Tammela T, Enholm B, Alitalo K et al (2005) The biology of vascular endothelial growth factors. Cardiovasc Res 65:550–563CrossRefPubMed
40.
Zurück zum Zitat Cao RH, Bjorndahl MA, Religa P et al (2004) PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6:333–345CrossRefPubMed Cao RH, Bjorndahl MA, Religa P et al (2004) PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6:333–345CrossRefPubMed
Metadaten
Titel
Nerve Growth Factor-β Expression Is Associated with Lymph Node Metastasis and Nerve Infiltration in Human Hilar Cholangiocarcinoma
verfasst von
Lei-bo Xu
Chao Liu
Guo-quan Gao
Xian-huan Yu
Rui Zhang
Jie Wang
Publikationsdatum
01.05.2010
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 5/2010
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-010-0417-4

Weitere Artikel der Ausgabe 5/2010

World Journal of Surgery 5/2010 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.